KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer

Clinical trial NCT05985109 · RECRUITING

Trial details

NCT number: NCT05985109
Sponsor: Peking University Cancer Hospital & Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2023-10-26
Primary completion: 2026-12-31
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.